Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Communications tags : Pharma save search
UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals
Published: 2024-04-03 (Crawled : 13:00) - biospace.com/
URGN | $14.57 -3.51% -3.64% 410K
|
Health Technology
|
| O: -0.64%
H: 0.71%
C: -2.43%
pharma patent pharmaceuticals teva
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
EVOK | $0.479 0.8% 0.79% 25K
|
Health Technology
|
| O: -4.68%
H: 5.88%
C: -3.58%
pharma year financial results
Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent
Published: 2023-11-27 (Crawled : 13:30) - globenewswire.com
EVOK | $0.479 0.8% 0.79% 25K
|
Health Technology
|
| O: 0.0%
H: 10.52%
C: 4.0%
fda pharma patent gimoti
Evoke Pharma Reports Second Quarter 2023 Financial Results
Published: 2023-08-10 (Crawled : 12:20) - globenewswire.com
EVOK | $0.479 0.8% 0.79% 25K
|
Health Technology
|
| O: 1.09%
H: 3.94%
C: 1.08%
pharma financial results
Aeon Pharma Again Tries the SPAC Route – Orange County Business Journal
Published: 2023-06-30 (Crawled : 18:00) - spacfeed.com
USCT | $11.23 0.27% 160
|
n/a
| Email alert
Add to watchlist
FNCTF | $11.128 -20.84% 580
|
Communications
| Email alert
Add to watchlist
pharma business spac
Evoke Pharma Reports First Quarter 2023 Financial Results
Published: 2023-05-15 (Crawled : 20:00) - globenewswire.com
EVOK | $0.479 0.8% 0.79% 25K
|
Health Technology
|
| O: 3.85%
H: 0.0%
C: -6.0%
pharma financial results
United States Patent and Trademark Office (USPTO) Grants Evoke Pharma a Formulation Patent Covering GIMOTIThe Company Will Submit for FDA Orange-Book Listing in the Near Term
Published: 2023-04-20 (Crawled : 14:20) - biospace.com/
FNCTF | $11.128 -20.84% 580
|
Communications
|
| O: -0.47%
H: 0.0%
C: 0.0%
EVOK | $0.479 0.8% 0.79% 25K
|
Health Technology
|
| O: 15.24%
H: 0.0%
C: -11.57%
fda pharma patent grants
aTyr Pharma Presents Preclinical Research Demonstrating Treatment with ATYR2810 Inhibits Tumor Growth and Therapy Resistance in Highly Aggressive Cancers at the 2023 AACR Annual Meeting
Published: 2023-04-17 (Crawled : 14:00) - biospace.com/
LIFE | $1.61 -5.29% -5.59% 360K
|
Health Technology
|
| O: 1.05%
H: 1.04%
C: -0.52%
atyr2810 pharma treatment tumor research preclinical meeting therapy growth
Lantern Pharma Receives Notice of Allowance for Composition of Matter Patent Covering Drug Candidate LP-284
Published: 2023-04-13 (Crawled : 12:20) - biospace.com/
LTRN | $6.05 1.34% 1.32% 200K
|
Health Technology
|
| O: 0.0%
H: 2.32%
C: 0.6%
lp-284 pharma drug patent candidate
Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI-Related Patent
Published: 2023-04-06 (Crawled : 13:00) - globenewswire.com
FNCTF | $11.128 -20.84% 580
|
Communications
|
| O: -0.36%
H: 0.0%
C: 0.0%
EVOK | $0.479 0.8% 0.79% 25K
|
Health Technology
|
| O: 0.51%
H: 5.64%
C: 3.59%
pharma patent
Sumitomo Pharma Subsidiary Companies in the U.S., Including Sumitomo Pharma Oncology, to Combine and Form Sumitomo Pharma America
Published: 2023-04-03 (Crawled : 14:00) - prnewswire.com
FNCTF | $11.128 -20.84% 580
|
Communications
| Email alert
Add to watchlist
america pharma companies
Onchilles Pharma Announces Presentation of Preclinical Data for N17350 at AACR 2023
Published: 2023-03-14 (Crawled : 00:00) - biospace.com/
FNCTF | $11.128 -20.84% 580
|
Communications
| Email alert
Add to watchlist
pharma preclinical presentation
Vincerx Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023
Published: 2023-03-14 (Crawled : 21:00) - globenewswire.com
VINC | $0.9393 7.97% 7.38% 900K
|
|
| O: 0.0%
H: 9.47%
C: 0.11%
pharma research meeting association cancer
USPTO Grants New Patent to Evoke Pharma Covering the Usage of GIMOTI® To Treat Moderate to Severe Gastroparesis
Published: 2022-12-07 (Crawled : 14:00) - globenewswire.com
EVOK | $0.479 0.8% 0.79% 25K
|
Health Technology
|
| O: -3.03%
H: 54.17%
C: 40.97%
gimoti pharma patent grants
Evoke Pharma Strengthens its Intellectual Property Portfolio with a Notice of Allowance from the USPTO for a Patent Application Related to GIMOTI®
Published: 2022-11-30 (Crawled : 14:00) - biospace.com/
EVOK | $0.479 0.8% 0.79% 25K
|
Health Technology
|
| O: -6.04%
H: 10.71%
C: 7.14%
gimoti pharma patent application
Evoke Pharma to Participate in the 2022 American College of Gastroenterology Annual Scientific Meeting
Published: 2022-10-20 (Crawled : 13:00) - globenewswire.com
FNCTF | $11.128 -20.84% 580
|
Communications
|
| O: -4.03%
H: 4.09%
C: 4.09%
EVOK | $0.479 0.8% 0.79% 25K
|
Health Technology
|
| O: 1.16%
H: 1.72%
C: 0.57%
pharma meeting
EIP Pharma Publishes Translational Data of Preclinical and Phase 2a Results for Neflamapimod in Dementia with Lewy Bodies: Nature Communications
Published: 2022-09-21 (Crawled : 10:00) - biospace.com/
FNCTF | $11.128 -20.84% 580
|
Communications
|
| O: -5.38%
H: 0.0%
C: 0.0%
dementia pharma preclinical communications phase 2b
Evoke Pharma Receives Notice of Allowance from USPTO for a Patent Related to GIMOTI
Published: 2022-09-20 (Crawled : 13:20) - biospace.com/
EVOK | $0.479 0.8% 0.79% 25K
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: -3.2%
pharma patent gimoti
Evoke Pharma Expands IP Portfolio with Addition of Canadian Patent Covering GIMOTI Method of Use
Published: 2022-07-06 (Crawled : 13:00) - biospace.com/
EVOK | $0.479 0.8% 0.79% 25K
|
Health Technology
|
| O: 2.93%
H: 3.8%
C: 3.48%
pharma patent gimoti
CRO Data Integrity Concerns Have Pharma Companies Scrambling to Repeat Bioequivalence Studies
Published: 2021-09-29 (Crawled : 18:00) - biospace.com/
FNCTF | $11.128 -20.84% 580
|
Communications
|
| O: -4.41%
H: 3.68%
C: 3.68%
pharma
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.